Health disorders in women can be caused by many abnormalities in the body...
ImmunoPrecise to Lead Scientific Round-table Discussion
At hubXchange’s European Antibody Therapeutics event, Debby Kruijsen will lead a round-table discussion entitled 'Implementing discovery strategies to value the therapeutic potential of lead antibody candidates' while Nienke Smits will present a poster entitled 'DeepDisplay™: a powerful and unique human lead antibody discovery platform utilizing OmniMouse®'.
Myalepta (metreleptin) for the Treatment of Lipodystrophy
Myalepta® (metreleptin) is a recombinant human leptin analogue indicated to treat complications of congenital or acquired generalised lipodystrophy.
Besremi (ropeginterferon alfa-2B) to Treat Polycythaemia Vera
Besremi® (ropeginterferon alfa-2B) is a mono-pegylated proline interferon indicated for the treatment of polycythaemia vera. It is one of the first of its kind to be approved for the condition.
Crysvita (burosumab-twza) for Treating X–Linked Hypophosphatemia
Crysvita® (burosumab-twza) is a fibroblast growth factor 23 (FGF23) blocking antibody indicated for the treatment of X-linked hypophosphatemia (XLH) in adults and children.
Poteligeo for the Treatment of Mycosis Fungoides and Sezary Syndrome
Poteligeo® (mogamulizumab-kpkc) is a monoclonal antibody (mAb) indicated for the treatment of mycosis fungoides and Sézary syndrome in adults.
Vizimpro (dacomitinib) for the Treatment of Non-Small Cell Lung Cancer
Vizimpro® (dacomitinib) is a kinase inhibitor indicated for the treatment of EGFR-positive advanced non-small cell lung cancer (NSCLC) patients diagnosed with exon 19 deletion or exon 21 L858R substitution mutations.
Eligen® Technology Mechanism of Action
Emisphere's Eligen® Technology binds a delivery agent with a therapeutic compound without alternation. This process occurs when both agent and compound are in close proximity.
Deals this week: Voyager Therapeutics, Pulmatrix, Horizon Discovery
Voyager Therapeutics will develop and commercialise Neurocrine Biosciences' gene therapy candidates used to treat severe neurological conditions after a collaboration was formed.
B&W Tek NanoRam Handheld Raman Spectrometer
The NanoRam is a state-of-the-art handheld Ramen instrument for non-destructive identification and verification of incoming raw materials such as active pharmaceutical ingredients (API), excipients, and intermediates.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.